KYORIN Pharmaceutical
4569.TSE
7.07 USD
0.11
+1.58%
k
Overview
Last close
7.07 usd
Market cap
405.91M usd
52 week high
11.04 usd
52 week low
6.62 usd
Target price
6.96 usd
Valuation
P/E
29.5316
Forward P/E
8.547
Price/Sales
0.5101
Price/Book Value
0.4619
Enterprise Value
449.95M usd
EV/Revenue
0.563
EV/EBITDA
7.5883
Key financials
Revenue TTM
795.51M usd
Gross Profit TTM
319.90M usd
EBITDA TTM
42.94M usd
Earnings per Share
0.24 usd
Dividend
0.36 usd
Total assets
1.16B usd
Net debt
58.90M usd
About
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
- Symbol4569.TSE
- ExchangeTSE
- IsinJP3247090008
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Yutaka Ogihara
- HeadquarterTokyo
- Web sitehttps://www.kyorin-pharm.co.jp
